JNJ-440

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameJNJ-440
Drug Alias NameALS-003440JNJ-440JNJ-0440JNJ-64530440
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCapsid protein modulators
TargetsCapsid protein
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAlios Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJanssen Pharmaceutical KkJanssen Research & Development Llc
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A